Clinical Trials Browser

Phase 1 × INDUSTRY × Erythroplasia × Clear all

NCT03939364 2021-10-19

This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions

Phase 1 Withdrawn

Erythroplasia, Leukoplakia, Oral